• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Microbiol Methods . Construction and application of MS2 bacteriophage virus-like particles for SARS-CoV-2 detection using a single-plasmid system

tetano

Editor, Senior Moderator
J Microbiol Methods


. 2025 Nov 25:107344.
doi: 10.1016/j.mimet.2025.107344. Online ahead of print. Construction and application of MS2 bacteriophage virus-like particles for SARS-CoV-2 detection using a single-plasmid system

Mengjie Liang[SUP] 1 [/SUP], Yongxin Li[SUP] 1 [/SUP], Jingyuan Yang[SUP] 1 [/SUP], Chunyan Liu[SUP] 1 [/SUP], Haojie Lin[SUP] 1 [/SUP], Zhaohui Deng[SUP] 2 [/SUP], Xin Zhang[SUP] 3 [/SUP]



Affiliations
Abstract

Research on the compatibility of MS2 bacteriophage virus-like particles (VLPs), which are used for the detection of a range of RNA viruses, with commercially available detection kits is limited. Here, we aimed to construct a positive control for RNA virus nucleic acid detection using MS2 bacteriophage VLPs and evaluate its compatibility with commercial nucleic acid detection kits to support the standardization of molecular diagnostic quality control systems. We generated recombinant plasmids expressing MS2 bacteriophage maturation enzyme, capsid proteins, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) target genes (ORF1ab, N, and E) using a single-plasmid dual-expression system (pACYCDuet-1). The plasmids were expressed in Escherichia coli BL21, and then MS2 VLPs were purified. The VLPs were characterized, and their performance as a positive control was validated for homogeneity and stability; their detection compatibility with five commercial SARS-CoV-2 nucleic acid detection kits was also examined. We successfully generated MS2 VLPs carrying SARS-CoV-2 target genes, with a uniform particle size of 23-28 nm and target gene copy number of 1.99 × 10[SUP]10[/SUP] copies/μL. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis confirmed the expression of MS2 proteins, whereas functional validation revealed excellent nuclease resistance, batch-batch homogeneity, and stability at 4 °C for ≥20 days. Importantly, the positive control exhibited consistent detection performance across all five commercial kits, confirming its practicality for routine laboratory workflows. The established positive control is readily applicable for standardizing quality control in molecular diagnostics.

Keywords: MS2 bacteriophage; Nucleic acid detection; Positive control; SARS-CoV-2; Virus-like particles.

 
Back
Top